Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Complex PCI: Complex Characteristics Impact Results

Patients with a bigger number of complex anatomical characteristics that increase PCI complexity have worse results at one-year followup.

Angioplastias complejas

These data come from a large multicenter study (e-Ultimaster) recently published in EuroIntervention.

The more complex the characteristics, the greater the increase in events. 

It is important to see past the obvious anatomical challenges (bifurcations, calcification, multivessel disease, etc.) and keep a wider perspective. A patient is much more than their coronary arteries. Complexity procedure also contributes (atherectomy, hemodynamic support).

PCI complexity is not a binary variable. There is an infinite range of greys in between with a dose/response outcome curve. Each point contributes to complexity and to increased hazard ratio. 


Read also: Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks.


In this study in particular, the authors define complexity based on factors used by the 2017  European guidelines for dual antiplatelet therapy. These factors give us a general idea, but we still need a standardized definition. 

The analysis included 35839 patients (mean age 64) undergoing coronary PCI between 2014 and 2018 with Ultimaster DES.

Risk characteristics were: multivessel disease, at least three stents, at least three lesions, bifurcations with at least 2 stents, total length covered with stents of 60 mm or more and chronic total occlusion. 27.3% of patients presented at least one risk characteristic but the vast majority presented more than one (73.3%), most frequently multivessel PCI, with 16.3%.


Read also: Death, Stroke, and Hospitalization while Waiting for TAVR.


Patients with more risk characteristics tended to be older, have more comorbidities, and chronic coronary syndrome. 

At one-year followup, target vessel failure rate was significantly higher in patients with at least one risk characteristic vs. patients with no risk characteristics for both the combined end point and its separate components. End points such as cardiac death (HR 1.28; CI 95% 1.05-1.55), target vessel related MI (HR 1.48; CI 95% 1.18-1.86) and clinically driven revascularization (HR 1.42; CI 95% 1.20-1.68) were associated to PCI complexity. 

Increased risk characteristics involve increased adverse events rate which, in addition to the ones mentioned, includes stent thrombosis. 


Read also: Long-Term Cardiovascular Effects of COVID-19.


Bifurcations increased target vessel failure rate by close to 100% (HR 2.01; 95% CI 1.55-2.62).

Bleeding risk resulted similar in both groups at 30 days, but after a year, patients with complex PCI characteristics had more bleeding events. 

This might be explained because some risk factors are common to both ischemic and bleeding events, such as hypertension, diabetes, kidney failure and old age. 

impact-of-coronary-lesion-complexity-in-percutaneous-coronary-intervention-one-y

Original Title: Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry.

Reference: Mohamed MO et al. EuroIntervention. 2020;16:603-612.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...